Mayne Pharma (#ASX: $MXY) has entered into a long-term supply agreement with Novast Laboratories Limited for thirteen US generic oral contraceptive products, including five new products not previously marketed by the Company. https://t.co/9wAGm1w9YD. #Pharmaceutical #drug #Stocks https://t.co/zVfFX94vAU